On Friday, JPMorgan Chase & Co. (NYSE:JPM)’s shares declined -0.21% to $60.85.
JPMorgan Chase & Co. (JPM) declared that in accordance with the terms of the outstanding warrants to purchase common stock of JPMorgan Chase (NYSE: JPM/WS), the warrant Exercise Price will be reduced to $42.284 per share from $42.325 per share, effective as of the close of business on October 6, 2015.
This adjustment resulted from the declaration by the Board of Directors of JPMorgan Chase on September 15, 2015 of a quarterly dividend of $0.44 per share on the outstanding shares of the Firm’s common stock. The dividend is payable on October 31, 2015, to stockholders of record at the close of business on October 6, 2015. This dividend declaration did not result in a change in the Warrant Share Number.
JPMorgan Chase & Co. provides various financial services worldwide. The company operates through four segments: Consumer & Community Banking, Corporate & Investment Bank, Commercial Banking, and Asset Administration.
Illumina, Inc. (NASDAQ:ILMN)’s shares gained 4.07% to $163.61.
Illumina, Inc. (ILMN) declared several new additions to BaseSpace—the world’s largest and most comprehensive cloud computing environment—with the launch of BaseSpace Professional and Enterprise Editions, fully integrated Laboratory Information Administration System (LIMS) solutions and advanced infrastructure upgrades.
BaseSpace is the only genomics platform that integrates sample set-up, instrument and sequencing run monitoring together with storage, analysis and sharing of large volumes of genomic data. The analysis platform is presently processing data from more than 4,000 sequencing systems worldwide, counting Illumina’s population-scale sequencing system, HiSeq X™ Ten, and providing push-button analytics with over 60 apps to more than 30,000 registered users.
Illumina, Inc. provides sequencing and array-based solutions for genetic analysis in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa. The company’s products comprise sequencing platforms that are based on its SBS technology, which provides researchers with various ranges of applications and the ability to sequence mammalian genomes; and array platforms comprise of HiScan and iScan systems, in addition to NextSeq 550 system that are array scanners for DNA and RNA analysis applications, counting single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis.
At the end of Friday’s trade, Amgen, Inc. (NASDAQ:AMGN)‘s shares surged 1.60% to $142.47.
Amgen (AMGN) will present at the Barclays Biosimilars Symposium at 8 a.m. ET on Wednesday, Oct. 7, 2015, in New York City. Scott Foraker, vice president and general manager of Biosimilars at Amgen, will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen’s website, www.amgen.com, under Investors. A replay of the webcast will also be accessible on Amgen’s website for at least 90 days following the event.
Amgen Inc., a biotechnology company, discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses for the treatment of illness in the areas of oncology, hematology, inflammation, bone health, nephrology, cardiovascular, and general medicine.
Fifth Third Bancorp (NASDAQ:FITB), ended its Friday’s trading session with -1.53% loss, and closed at $18.68.
Fifth Third Bank declared its sponsorship of 170,000 students for financial education starting with the fall semester of the new 2015-2016 school year. The Bank is underwriting Dave Ramsey’s Foundations in Personal Finance course in 1,637 high schools within the Bank’s footprint.
Fifth Third has assisted deliver Foundations in Personal Finance in high schools for the past six years. Since 2010, the Bank has assisted educate more than 800,000 students on its way to educating a record one million students by the spring of 2017.
Fifth Third Bancorp operates as a diversified financial services company in the United States. It operates through four segments: Commercial Banking, Branch Banking, Consumer Lending, and Investment Advisors.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
